| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $2.5M | +54.0% |
| SG&A Expense | $7.2M | -16.0% |
| Operating Income | -$9.6M | +4.9% |
| Pre-tax Income | -$9.3M | +5.5% |
| Income Tax | -$30K | +0.0% |
| Net Income | -$9.3M | +5.5% |
| EPS (Basic) | -$7.40 | -873.7% |
| EPS (Diluted) | -$7.40 | -873.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $864K | -71.3% |
| Inventory | $1.9M | +9.3% |
| Current Assets | $3.2M | -34.4% |
| Total Assets | $7.3M | -38.0% |
| Current Liabilities | $5.2M | +40.4% |
| Total Liabilities | $5.3M | +37.9% |
| Stockholders' Equity | $2.0M | -74.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.9M | +18.5% |
| Capital Expenditures | $139K | -80.1% |
| Investing Cash Flow | -$1.2M | -66.6% |
| Financing Cash Flow | $5.9M | -26.4% |
| Free Cash Flow | -$7.1M | +23.2% |